New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 51, Issue 3, Pages 324-332
Publisher
Springer Nature
Online
2015-11-23
DOI
10.1038/bmt.2015.288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases
- (2015) Hilary L. Haines et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies
- (2015) Biljana Horn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
- (2015) Thomas Schroeder et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT
- (2015) Chen-Hua Yan et al. CLINICAL TRANSPLANTATION
- Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation
- (2015) Hisayoshi Hashimoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients
- (2014) J Gozdzik et al. BONE MARROW TRANSPLANTATION
- A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent
- (2014) J J Scarisbrick et al. BONE MARROW TRANSPLANTATION
- The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation
- (2014) Xiao-su Zhao et al. CLINICAL TRANSPLANTATION
- Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies
- (2013) David Serrano et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose
- (2013) Merav Bar et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation
- (2013) Anita J. Kumar et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation
- (2013) Amer M. Zeidan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
- (2013) D. H. Fowler et al. BLOOD
- HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion
- (2013) S. Stevanovi et al. BLOOD
- Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
- (2013) C. R. Y. Cruz et al. BLOOD
- Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion
- (2013) P. Bachireddy et al. BLOOD
- Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
- (2013) J. N. Kochenderfer et al. BLOOD
- Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
- (2013) M Eefting et al. BONE MARROW TRANSPLANTATION
- Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
- (2013) A J Innes et al. BONE MARROW TRANSPLANTATION
- A single course of all-trans retinoic acid plus arsenic trioxide reached a long-term survival in a patient with newly diagnosed acute promyelocytic leukemia: a suggestion for reduction of treatment courses?
- (2013) Jinsong Yan et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies
- (2013) Najla El-Jurdi et al. Immunotherapy
- Immunotherapy following relapse of acute leukaemia after T-cell-replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft-versus-host disease
- (2013) C. Curley et al. International Journal of Laboratory Hematology
- Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
- (2013) T Schroeder et al. LEUKEMIA
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
- (2013) E. H. Warren et al. TISSUE ANTIGENS
- Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
- (2013) Franco Locatelli et al. Frontiers in Immunology
- CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation
- (2012) E.M. Wagner et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
- (2012) Pramila Krishnamurthy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease
- (2012) Caroline E. Rutten et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
- (2012) Willemijn Hobo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
- (2012) Maria Liga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
- (2012) J. C. Riches et al. BLOOD
- Donor lymphocyte infusions for relapse after allogeneic transplantation. When, if and for whom?
- (2012) Ying-Jun Chang et al. BLOOD REVIEWS
- The EBMT activity survey: 1990–2010
- (2012) J R Passweg et al. BONE MARROW TRANSPLANTATION
- G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation
- (2012) K K S Abbi et al. BONE MARROW TRANSPLANTATION
- Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors
- (2012) Chen-Hua Yan et al. CLINICAL TRANSPLANTATION
- Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study
- (2012) Yu Wang et al. CLINICAL TRANSPLANTATION
- Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?
- (2012) Hakon Reikvam et al. CURRENT CANCER DRUG TARGETS
- Donor CD3+ lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: Single-center experience
- (2012) Jean El-Cheikh et al. EXPERIMENTAL HEMATOLOGY
- IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
- (2012) Zhi-Zhang Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Successful haploidentical PBSCT with subsequent T-cell addbacks in a boy with HyperIgM syndrome presenting as severe congenital neutropenia
- (2012) Aleksandra Jasinska et al. PEDIATRIC TRANSPLANTATION
- Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: The composition in collection
- (2012) Cheng Zhang et al. TRANSFUSION AND APHERESIS SCIENCE
- Immunomodulatory strategies for relapse after haploidentical hematopoietic stem cell transplantation in hematologic malignancy patients
- (2011) Xiao-Jun Huang BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation
- (2011) Erica D. Warlick et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft
- (2011) J Hasskarl et al. BONE MARROW TRANSPLANTATION
- Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity
- (2011) T Guillaume et al. BONE MARROW TRANSPLANTATION
- Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis
- (2011) Y Wang et al. BONE MARROW TRANSPLANTATION
- Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation
- (2011) Betul Oran et al. CURRENT OPINION IN HEMATOLOGY
- Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
- (2011) Claire Roddie et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies
- (2011) D. L. Porter Hematology-American Society of Hematology Education Program
- Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) Evgeny Klyuchnikov et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited
- (2010) Abhinav Deol et al. CANCER TREATMENT REVIEWS
- Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) S. Maury et al. Science Translational Medicine
- Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect
- (2009) X-J Huang et al. BONE MARROW TRANSPLANTATION
- Management of relapse after allo-SCT for AML and the role of second transplantation
- (2009) B N Savani et al. BONE MARROW TRANSPLANTATION
- Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
- (2009) Y Chalandon et al. BONE MARROW TRANSPLANTATION
- Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
- (2009) M Lübbert et al. BONE MARROW TRANSPLANTATION
- Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells
- (2009) Claudia Wrzesinski et al. JOURNAL OF IMMUNOTHERAPY
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
- (2009) Fabio Ciceri et al. LANCET ONCOLOGY
- Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles
- (2009) B E Shaw et al. LEUKEMIA
- Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation
- (2008) Benjamin Gesundheit et al. AMERICAN JOURNAL OF HEMATOLOGY
- Graft-versus-host disease after donor leukocyte infusions: presentation and management
- (2008) Noelle V. Frey et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism
- (2008) T. Kawase et al. BLOOD
- Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population
- (2008) J E Levine et al. BONE MARROW TRANSPLANTATION
- Donor lymphocyte infusions: the long and winding road: how should it be traveled?
- (2008) M Tomblyn et al. BONE MARROW TRANSPLANTATION
- Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started